Non-small cell lung cancer (NSCLC) is the third most common type of cancer in the Unites States (US). It is known to harbor many types of mutations, making it particularly difficult to define the best treatment algorithm for a patient, especially after first line treatment. Over the last few ...
-1.jpg?width=40&name=Untitled%20design%20(1)-1.jpg){kind=avatar}
Tori Gray, PharmD Candidate & Megan B May, PharmD, BCOP
Read more
